Navigation Links
Selexis SA to Present at Biotech Showcase 2012
Date:1/5/2012

GENEVA, Switzerland, Jan. 5, 2012  /PRNewswire/ -- Selexis SA announced today the Company's president and CEO, Igor Fisch, Ph.D., will present at the Biotech Showcase 2012 Conference held in conjunction with the annual J.P. Morgan Healthcare Conference in San Francisco, CA.

Dr. Fisch will present, "Translating Drug Discovery into Clinical Success: A Growth Investment" to prospective investors and corporate partners on Monday, January 9 at 11:00 AM in the Stockton Room at the Park 55 Wyndham.   The presentation will cover existing commercial offerings, the expansion of the SUREtechnology Platform™ and new market opportunities in drug discovery, next generation biologics and difficult to express proteins. 

"Biotech Showcase is an ideal opportunity for us to highlight our innovations and our applications of the SUREtechnology Platform™ supporting the biopharmaceutical industry's drug discovery efforts," said Dr. Fisch.  "Using Selexis' platform from discovery through manufacturing helps improve chances of clinical success while reducing development timelines and costs."

About Selexis SA

Headquartered in Geneva, Switzerland, Selexis SA is a global life science company with innovative technologies and world-class expert services for drug discovery, cell line development and scale-up to manufacturing of therapeutic proteins.  The Company's SUREtechnology Platform™ is based on Selexis Genetic Elements™ -- novel DNA-based elements that control the dynamic organization of chromatin within all mammalian cells and allow for higher and more stable expression of recombinant proteins. Selexis has generated over 1,300 cell lines being used in a variety of programs from drug discovery to late-stage clinical trials.  The Company anticipates three products manufactured from cell lines using the Selexis SUREtechnology Platform™ to be launched in 2012.

For more information, visit http://www.selexis.com

Selexis SA
Robert Meister
robert.meister@selexis.com
(602) 953-1716


'/>"/>
SOURCE Selexis SA
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Selexis Launches Biosimilar Cell Line Development Program
2. Irvine Scientific and Selexis to Announce Results of Successful Collaboration
3. Selexis SA Doubles Cell Line Development Laboratory Space in Geneva, Switzerland
4. Selexis SA and the University of Lausanne Announce the Complete Sequencing of the Selexis SURE CHO-M Genome
5. Selexis SA to Partner and Exhibit at BIO 2011 in Washington DC
6. Selexis SA to Give Away Euro 25,000 SUREvariant Screening Service Project at BIO 2011
7. CSL Limited Signs Commercial License Agreement with Selexis SA
8. InterMune to Present at Canaccord Adams Conference
9. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2008
10. Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference
11. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CANACCORD ADAMS 28TH ANNUAL GLOBAL GROWTH CONFERENCE
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2019)... (PRWEB) , ... January 15, 2019 , ... Personalized treatment ... for worsening kidney disease, according to a new study published in the journal Radiology. ... are frequently treated with partial nephrectomy, a surgical procedure in which the tumor and ...
(Date:1/11/2019)... ... January 11, 2019 , ... Boekel Scientific launches its ... donor blood. This advanced and intuitive medical device was designed in conjunction ... needed for the busiest donor stations with new-to-the industry features to improve efficiency ...
(Date:1/10/2019)... ... ... from a local shelter when he was around two years old. According to his ... he was adopted, he tore his right cruciate ligament. Though he had his ACL ... traumatic injury. , Sure enough, when Rascal was about nine years old, he began showing ...
(Date:1/10/2019)... ... ... VGI Medical was founded in 2007 based on an invention developed by Tov ... VerteLoc, CerLoc, SiJoin and VerteLP. The VerteLoc and CerLoc systems are specifically designed to ... to limit motion of the affected spinal segment. Applying the principles of this success, ...
Breaking Biology Technology:
(Date:2/2/2019)... ... January 31, 2019 , ... ... headquartered in Morrisville, NC, providing full, customizable clinical research services across multiple ... support educational programs for early stage life science entrepreneurs in the Research ...
(Date:1/30/2019)... NEW YORK (PRWEB) , ... ... ... a nonprofit organization that identifies, counsels, and supports high-growth, high-impact life science ... investment professionals representing 10 national nonprofit disease foundations and disease-focused venture funds ...
(Date:1/25/2019)... ... January 24, 2019 , ... GrowthZone, Inc., provider ... The report indicates membership growth in some sectors and decreasing membership among others. ... responses from over 500 association professionals across North America. , “This year’s ...
Breaking Biology News(10 mins):